About
Fredrik Lehmann focuses on life science and biotech investments at Industrifonden, which he joined in 2022. He has over 20 years of experience in the life science industry in roles including CEO, Head of Research, and CMC, and has founded six companies, including OnTarget Chemistry, which Recipharm acquired in 2015. He holds a PhD in medicinal chemistry from Gothenburg University and an MBA from the Stockholm School of Economics.
Invests in
BiotechHealthtech
Experience
- Renity PharmaFoundercurrent2025 — presentStockholm
- LIPUM ABChairperson of the Boardcurrent2026 — presentStockholm
- FlerieSenior Advisorcurrent2026 — presentStockholm
- IndustrifondenVenture Partnercurrent2022 — presentStockholm, Stockholm County, Sweden
- SynartroCo-Founder and chairman of the boardcurrent2011 — presentUppsala, Sweden
- Sprint BioscienceMember Board Of Directors at Sprint Biosciencecurrent2019 — presentStockholm, Sweden
- OT PharmaDrug development consultantcurrent2015 — present
- Guard TherapeuticsBoard Member2022 — 2026Stockholm, Stockholm County, Sweden
- AnaCardioBoard Member2022 — 2026Stockholm
- Teitur TrophicsBoard Member2023 — 2026Copenhagen
- Sound BioventuresEntrepreneur in Residence2023 — 2025Stockholm, Stockholm County, Sweden
- Oncopeptides ABHead of Research and CMC2008 — 2022Stockholm, Sweden
- EpiEndo PharmaceuticalsCEO2018 — 2021Reykjavik
- Recipharm OT Chemistry ABGeneral Manager2016 — 2018Uppsala, Sweden
- OnTarget ChemistryCEO2009 — 2016Uppsala, Sweden
- AxelarCMC Director2011 — 2012
- Akinion Pharmaceuticals ABCMC Director2009 — 2012
- Sobi - Swedish Orphan Biovitrum AB (publ)Medicinal Chemist2006 — 2009Stockholm, Sweden
- Göteborg UniversityPhD student2002 — 2007
- Sobi - Swedish Orphan Biovitrum AB (publ)Medicinal Chemist2001 — 2002Uppsala, Sweden
Education
- Stockholm School of EconomicsMBA2020 — 2021
- University of GothenburgPhD, Medicinal Chemistry2002 — 2007
- Uppsala UniversityFil Mag, Organic Chemistry1995 — 2000
Skills & more
Board LeadershipStart-up VenturesCompany Set-upEarly Stage InvestmentSeed CapitalStartup EnvironmentsOperations ManagementNeurodegenerative Disease1Cardiovascular Disease1Strategy2Board GovernanceOutsourcing
+12 more
INDIMPDNew Drug Application (NDA)MAAVenture CapitalInvestmentsBiotechnology IndustryDrug DiscoveryCMCMedicinal ChemistryDrug DesignOrganic SynthesisLanguages English
From Fredrik's professional profile.
Same school
Also attended Stockholm School of Economics172
Mattias LjungmanInvestor at Moonfire VenturesPär-Jörgen PärsonPartner at NorthzoneDominik EsenPrincipal at NorthzoneAndrea GazviniAssociate at NorthzoneLouise HagenInvestor at Luminar VenturesViktor BerggrenTechnology Investor at Marlin Equity Partners
+ 166 more
Also attended University of Gothenburg43
Martin Boldt-ChristmasInvestor at Green FlagPelle TornbergInvestor at FELIX CAPITALJonathan IlickiInvestor at IndustrifondenDr. Christopher OsterFounder and former CEO of CLARK at PICUS CAPITALAnna GisselssonInvestor at Almi InvestEmma BurmanInvestor at Almi Invest
+ 37 more
Shared employers
Also worked at Sprint Bioscience1
Also worked at Oncopeptides AB2
Also worked at EpiEndo Pharmaceuticals1
Also worked at Sobi - Swedish Orphan Biovitrum AB (publ)2
Colleagues at Industrifonden
Andreas Hiller
Investor at Industrifonden
Andreas Söneby
Investor at Industrifonden
Anna Haupt
Investor at Industrifonden
Anna Ljungdahl
Investor at Industrifonden
Åsa Hedin
Investor at Industrifonden
Åsa Sundberg
Investor at Industrifonden
Birgitta Stymne Göransson
Investor at Industrifonden
Caroline Murray
Investor at Industrifonden